Trade-off between benefit and harm is crucial in health screening recommendations. Part II: Evidence summaries

Journal of Clinical Epidemiology

Volumn 64, Issue 3, 2011, Pages 240-249

  Silvestre, Maria Asuncion A ^a   Dans, Leonila F ^a   Dans, Antonio L ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Diagnostic test; Direct evidence; Evidence summary; Health screening; Indirect evidence; Screening program; Screening test

Indexed keywords

AROMATASE INHIBITOR; TAMOXIFEN;

ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CANCER SCREENING; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; GENETIC DISORDER; HUMAN; INFECTION; MAMMOGRAPHY; MEDICAL ETHICS; META ANALYSIS (TOPIC); PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCREENING TEST;

EID: 78751648135     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2010.09.008     Document Type: Review

References (74)

1. A. Barratt, G.P. Irwig, R. Cumming, A. Raffle, N. Hinks, and J.A. Muir Gray Moving from evidence to action: recommendations about screening User's guides to the medical literature 2008 The McGraw-Hill Companies, Inc USA p. 667
2. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure National heart, lung, and blood institute; national high blood pressure education program coordinating committee. seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Hypertension 42 2003 1206 1252 Epub 2003 Dec 1
3. G. Mancia, G. Grassi, European Society of Hypertension; European Society of Cardiology, and Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for evaluating and treating hypertension: a two-way road? J Am Soc Nephrol 16 Suppl 1 2005 S74 S77
4. U.S. Preventive Services Task Force Screening for high blood pressure: review of the evidence July 2003 Agency for Healthcare Research and Quality Rockville, MD Available at http://www.ahrq.gov/clinic/3rduspstf/highbloodsc/ hibloodrr.htm Accessed May 3, 2009
5. Screening for type 2 diabetes mellitus in adults. What's New from the USPSTF? AHRQ Publication No. APPIP03-0005 February 2003 Agency for Healthcare Research and Quality Rockville, MD
6. M.P. Pignone, C.J. Phillips, D. Atkins, S.M. Teutsch, C.D. Mulrow, and K.N. Lohr Screening and treating adults for lipid disorders Am J Prev Med 20 Suppl 3 2001 77 89
7. H.D. Nelson, M. Helfand, S.H. Woolf, and J.D. Allan Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 2002 529 541 (Pubitemid 35024625)
8. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, S.M. Moss, S.S. Amar, and T.W. Balfour Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 9040 1996 1472 1477
9. A.B. Miller, C.J. Baines, T. To, and C. Wall Canadian National Breast Screening Study, 1: breast cancer detection and death rates among women aged 40 to 49 years Can Med Assoc J 147 1992 1459 1476 (Pubitemid 23008476)
10. A. Ilicki, and A. Larsson Psychological development at 7 years of age in children with congenital hypothyroidism: timing and dosage of initial treatment Acta Paediatr Scand 80 1991 199 200
11. S. Heyerdahl, B.F. Kase, and S.O. Lie Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment J Pediatr 118 1991 850 857
12. S. Shapiro, W. Venet, P. Strax, L. Venet, and R. Roeser Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening Natl Cancer Instit Monogr 67 1985 65 74
13. R.J. Connor, P.C. Prorok, and D.L. Weed The case-control design and the assessment of the efficacy of cancer screening J Clin Epidemiol 44 1991 1215 1221
14. C.B. Begg Meta-analysis methods for diagnostic accuracy J Clin Epidemiol 61 11 2008 Nov 1081 1082 discussion 1083-1084
15. R.M. Harbord, P. Whiting, J.A. Sterne, M. Egger, J.J. Deeks, and A. Shang An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary J Clin Epidemiol 61 11 2008 Nov 1095 1103
16. A. Van den Bruel, I. Cleemput, B. Aertgeerts, D. Ramaekers, and F. Buntinx The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed J Clin Epidemiol 60 2007 Nov 1116 1122 Epub 2007 Aug 29
17. Canadian Task Force on the Periodic Health Examination The periodic health examination CMAJ 121 1979 1193 1254
18. D.L. Sackett Rules of evidence and clinical recommendations on the use of antithrombotic agents Chest 89 Suppl 2 1986 2S 3S
19. US Department of Health and Human Services, and Public Health Service, Agency Health Care Policy and Research Acute pain management: operative or medical procedures and trauma 1992 Agency for Health Care Policy and Research Publications Rockville, MD (AHCPR Pub 92-0038)
20. National Health and Medical Research Council How to use the evidence: assessment and application of scientific evidence 2000 AusInfo Canberra Available at www.health.gov.au/nhmrc/publications/pdf/cp69.pdf Accessed May 13, 2009
21. U.S. Preventive Services Task Force Grade Definitions. May 2008. Available at http://www.uspreventiveservicestaskforce.org/uspstf/grades.htm Aaccessed April 21, 2009.
22. GRADE Working Group Grading quality of evidence and strength of recommendations BMJ 328 2004 1490 1498
23. H.J. Schünemann, A.D. Oxman, J. Brozek, P. Glasziou, R. Jaeschke, G.E. Vist GRADE Working Group Grading quality of evidence and strength of recommendations for diagnostic tests and strategies BMJ 336 7653 2008 May 17 1106 1110 (Pubitemid 351731739)
24. K.M. Kash Psychosocial and ethical implications of defining genetic risk for cancers Ann N Y Acad Sci 30 1995 41 52
25. C. Ustun, and E. Ceber Ethical issues for cancer screenings. Five countries-four types of cancer Prev Med 39 2004 223 229
26. J.G. Elmore, M.B. Barton, V.M. Moceri, S. Polk, P.J. Arena, and S.W. Fletcher Ten-year risk of false positive screening mammograms and clinical breast examinations N Engl J Med 338 1998 1089 1096
27. National Guideline Clearinghouse (NGC) Guideline synthesis: screening for prostate cancer [website]. 1998 Dec 28 (updated 2005 Sep) National Guideline Clearinghouse (NGC) 2005 National Guideline Clearinghouse (NGC) Rockville, MD Available at http://www.guideline.gov Accessed July 9, 2007
28. Philippine Information Agency Available at http://www.pia.gov.ph/?m= 12&fi=p060925.htm&no=47 Accessed July 9, 2007
29. United States Preventive Services Task Force Preventive services [cited 2005 November 3] 2005 Agency for Healthcare Research and Quality Rockville, MD Available at http://www.ahrq.gov/clinic/uspstfix.htm Accessed July 9, 2007
30. R. Wilson, D. Asbury, J. Cooke, M. Michell, and J. Patnick NHS cancer screening programmes Clinical Guidelines for Breast Cancer Screening Assessment. NHSBSP Publication No. 49 2001 The Manor House Sheffield
31. Canadian Task Force on Preventive Health Care Evidence-based clinical prevention [cited 2005 November 3] 2000 Canadian Task Force on Preventive Health Care London, ON Available at http://www.ctfphc.org Accessed July 9, 2007
32. ACOG practice bulletin Breast cancer screening. Number 42 Int J Gynaecol Obstet 81 2003 313 323
33. Task Force on Neoplastic Diseases Chapter 9 screening for neoplastic diseases A.L. Dans, D.D. Morales, Philippine guidelines on periodic health examination: effective screening for diseases among apparently healthy Filipinos 2004 The Publication Program, University of the Philippines Manila Manila 247 278
34. H.D. Nelson, K. Tyne, A. Naik, C. Bougatsos, B.K. Chan, and L. Humphrey Screening for breast cancer: an update for the U.S. Preventive Services Task Force Ann Intern Med 151 2009 727 737
35. D. Maxwell Parkin, and L.M.G. Fernández Use of statistics to assess the global burden of breast cancer Breast J 12 Suppl 1 2006 S70 S80
36. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
37. Cancer in North America, 2000-2004. Volume One: Incidence, NAACCR, 2007.
38. American Cancer Society Statistics Available at http://www.cancer.org/ docroot/stt/stt-0.asp 2008 Accessed June 4, 2009
39. R. Egan Mammography as an aid to diagnosis of breast carcinoma J Am Med Assoc 182 1962 1075 1090
40. R. Clark, M. Copeland, and R. Egan Reproducibility of the techinique of mammography (Egan) for cancer of the breast Am J Surg 109 1965 127
41. S. Shapiro, W. Venet, P. Strax, and L. Venet Current results of the breast cancer screening randomized trial: the Health Insurance Plan (HIP) of greater New York study N.E. Day, A.B. Miller, Screening for breast cancer 1988 Hans Huber Toronto 3 15
42. L.L. Humphrey, M. Helfand, B.K.S. Chan, and S.H. Woolf Breast cancer screening: a summary of the evidence Ann Intern Med 137 2002 347 360
43. D. Miller, I. Martin, and P. Herbison Interventions for relieving the pain and discomfort of screening mammography Cochrane Database Syst Rev 4 2002 CD002942
44. K. Armstrong, E. Moye, S. Williams, J.A. Berlin, and E.E. Reynolds Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians Ann Intern Med 146 2007 516 526
45. S.A. Feig, and R.E. Hendrick Radiation risk from screening mammography of women aged 40-49 years J Natl Cancer Instit Monogr 22 1997 119 124
46. E.D. Pisano, J. Earp, M. Schell, K. Vokaty, and A. Denham Screening behavior of women after a false-positive mammogram Radiology 208 1998 245 249 (Pubitemid 28323337)
47. O. Ekeberg, H. Skjauff, and R. Karesen Screening for breast cancer is associated with a low degree of psychological distress Breast 10 2001 20 24
48. C. Lampic, E. Thurfjell, J. Bergh, and P.O. Sjoden Short- and long-term anxiety and depression in women recalled after breast cancer screening Eur J Cancer 37 2001 463 469
49. G. Meystre-Agustoni, F. Paccaud, A. Jeannin, and F. Dubois-Arber Anxiety in a cohort of Swiss women participating in a mammographic screening programme J Med Screen 8 2001 213 219
50. N.T. Brewer, T. Salz, and S.E. Lillie Systematic review: the long-term effects of false-positive mammograms Ann Intern Med 146 2007 502 510
51. J. Brett, C. Bankhead, B. Henderson, E. Watson, and J. Austoker The psychological impact of mammographic screening. A systematic review Psychooncology 14 2005 917 938
52. L.M. Schwartz, S. Woloshin, H.C. Sox, B. Fischoff, and H.G. Welch U.S. women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey Br Med J 320 2000 1635 1640
53. N.A. D Homesh, M.A. Issa, and H.A. El-sofiani The diagnostic accuracy of fine needle aspiration cytology versus core needle biopsy for palpable breast lump(s) Saudi Med J 26 1 2005 42 46
54. H.M. Verkooijen, P.H. Peeters, E. Buskens, V.C. Koot, I.H. Borel Rinkes, and W.P. Mali Diagnostic accuracy of large-core needle biopsy for nonpalpable breast disease: a meta-analysis Br J Cancer 82 2000 1017 1021
55. C.M. Kaelin, T.J. Smith, M.J. Homer, B. Taback, D. Azurin, and C.H. Schmid Safety, accuracy, and diagnostic yield of needle localization biopsy of the breast performed using local anesthesia J Am Coll Surg 179 1994 267 272
56. Early Breast Cancer Trialists' Collaborative Group Tamoxifen for early breast cancer Cochrane Database Syst Rev 1 2001 CD000486
57. Early Breast Cancer Trialists' Collaborative Group Ovarian ablation for early breast cancer Cochrane Database Syst Rev 3 2000 CD000485
58. L.J. Gibson, C.K. Dawson, D.H. Lawrence, and J.M. Bliss Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women Cochrane Database Syst Rev 1 Jan 24, 2007 CD003370
59. D. Ghersi, N. Wilcken, J. Simes, and E. Donoghue Taxane containing regimens for metastatic breast cancer Cochrane Database Syst Rev 2 Apr 18, 2005 CD003366
60. V. Vinh-Hung, and C. Verschraegen Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality J Natl Cancer Instit 96 2 2004 115 121 (Pubitemid 38195902)
61. A.F. Vitug, and L.A. Newman Complications in breast surgery Surg Clin North Am 87 2007 431 451
62. S.M. Spencer, J.M. Lehman, C. Wynings, P. Arena, C.S. Carver, and M.H. Antoni Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients Health Psychol 18 1999 159 168
63. M. Baum, R. Demicheli, W. Hrushesky, and M. Retsky Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases? Eur J Cancer 41 2005 508 515 Epub 2005 Jan 18
64. P.C. Gotzsche, and M. Nielsen Screening for breast cancer with mammography Cochrane Database Syst Rev 4 2006 10.1002/14651858.CD001877.pub2 CD001877
65. S. Shapiro Periodic screening for breast cancer: the HIP randomized controlled trial. Health Insurance Plan J Natl Cancer Instit Monogr 22 1997 27 30
66. A.B. Miller, T. To, C.J. Baines, and C. Wall The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years Ann Intern Med 137 5 Part 1 2002 305 312
67. A.B. Miller, T. To, C.J. Baines, and C. Wall Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years J Natl Cancer Instit 92 2000 1490 1499
68. S.M. Moss, H. Cuckle, A. Evans, L. Johns, M. Waller, L. Bobrow Trial Management Group Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial Lancet 368 9552 2006 2053 2060
69. N. Bjurstam, L. Bjorneld, J. Warwick, E. Sala, S.W. Duffy, and L. Nyström The Gothenburg Breast Screening Trial Cancer 97 2003 2387 2396
70. P. Salzmann, K. Kerlikowske, and K. Phillips Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Ann Intern Med 127 11 1997 955 965
71. J. Mandelblatt, S. Saha, S. Teutsch, T. Hoerger, Al Siu, D. Atkins for the Cost Work Group of the U.S. Preventive Services Task Force The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 139 10 Nov 18, 2003 835 842
72. D. Ilic, D. O'Connor, S. Green, and T. Wilt Screening for prostate cancer Cochrane Database Syst Rev 3 2006 10.1002/14651858:CD004720.pub2 CD004720
73. K. Marshall Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm Can Med Assoc J 155 4 1996 169 176
74. B. Marcheco, A.M. Bertoli, I. Rojas, and L. Heredero Attitudes and knowledge about presymptomatic genetic testing among individuals at high risk for familial, early-onset Alzheimer's disease Genet Test 7 1 Spring 2003 45 47